Navigation Links
UPM Signs Joint Development Agreement with Renmatix in Biochemicals
Date:6/11/2013

HELSINKI, June 11, 2013 /PRNewswire/ -- UPM (OMX: UPM1V) and Renmatix, Inc., have entered into a non-exclusive joint development agreement (JDA) in the area of biochemicals. Under terms of the JDA both companies will further develop Renmatix's water-based Plantrose™ process to convert woody biomass into low-cost sugar intermediates for subsequent downstream processing into biochemicals. Offering cost-competitive bio-alternatives for select petrochemicals on an industrial scale is the long term goal of this initiative.

"We are very excited about this truly collaborative endeavor. It combines UPM's core competencies in sustainable sourcing and efficient industrial processing of wood, with Renmatix's unique conversion technology," noted Michael Duetsch, Director of Biochemicals, at UPM. "Access to second generation, lignocellulosic, sugars through a process that uses almost no consumables is a crucial factor in Plantrose technology's attractiveness."

The Plantrose process employs water at very high temperatures and pressures to breakdown biomass through supercritical hydrolysis. Under such conditions water can act as both a powerful solvent and catalyst, creating rapid reactions.

"We believe this pioneering approach leads to real cost advantages over conventional methods. Our growing relationship with UPM gives Renmatix an opportunity to support them expanding the Biofore story," commented Mike Hamilton, CEO of Renmatix. "Renmatix, as a U.S. based technology provider, takes great pride in working with global companies across the emerging bio-value chains. It reinforces the demand that exists for licensing Plantrose technology as the bridge between sustainable sources of upstream biomass, and downstream manufacturing of biochemicals and fuels."

"The joint development agreement with Renmatix is another milestone in the implementation of our biochemicals strategy and UPM's Biofore vision. The co-operation further strengthens our position as the frontrunner in the innovation-driven integration of bio and forest industries," adds Juuso Konttinen, Vice President of UPM.

UPM leads the integration of bio and forest industries into a new, sustainable and innovation-driven future. Our products are made of renewable raw materials and are recyclable. UPM consists of three Business Groups: Energy and pulp, Paper, and Engineered materials. The Group employs around 22,000 people. UPM is present in 67 countries and has production units in 17 countries. UPM's annual sales exceed EUR 10 billion. UPM's shares are listed on the Helsinki stock exchange. UPM – The Biofore Company – www.upm.com

UPM New Businesses and Development (NBD) is an important part of UPM's renewal and Biofore strategy. The objective of NBD is to provide added value to renewable wood raw material by developing ideas into new products and businesses. The key projects are biocomposites, biofibrils and biochemicals.

Renmatix is the leading manufacturer of cellulosic sugar, an enabling feedstock for petroleum alternatives used in the global biochemical and biofuels markets. The company's proprietary Plantrose™ process challenges conventional sugar economics by cheaply converting cellulosic biomass – from wood waste to agricultural residue – into useful, cost-effective sugars. Renmatix's supercritical hydrolysis technology deconstructs non-food biomass an order of magnitude faster than other processes and enhances its cost advantage by using no significant consumables. Renmatix is privately held, with operations in Georgia (USA) currently capable of converting three dry tons of cellulosic biomass to Plantro® sugar per day, and a world-class technical center in Pennsylvania (USA). www.renmatix.com

For further information, please contact:
Michael Duetsch, Director, Biochemicals, UPM, +49.821.310.9130 (German, English)
Juuso Konttinen, Vice President, New Businesses & Development, UPM, +358.40.531.7405 (Finnish, English)
Duncan Cross, Director, Marketing, Renmatix, +484.751.4000 (English, French)
Tim Brown, Vice President, Corporate Strategy, Renmatix, businessdevelopment@renmatix.com

UPM, Corporate Communications
Media Desk, +358.40.588.3284
media@upm.com
www.twitter.com/UPM_News

Renmatix, Media Inquiries
Katie Struble, +415.977.1928
renmatix@antennagroup.com
www.twitter.com/renmatix


'/>"/>
SOURCE Renmatix
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Elsevier Signs Strategic Collaboration Agreement with Peoples Medical Publishing House, China
2. Alexandrias 499 Illinois Street in Mission Bay, San Francisco, Signs Anchor 97,700 Rentable Square Foot Lease with Leading Mid-Cap Life Science Company
3. Australian Distributor of Express Diagnostics Signs Sponsorship Agreement with V8 Supercar Team
4. Phosphagenics Signs Research Agreement with the Agricultural Research Service
5. Adaptive Biotechnologies Signs Biomarker Discovery Collaboration Agreement with Bristol-Myers Squibb
6. Vestiage Signs Buyside Engagement Agreement with CJK Securities
7. Vertilon Signs Crisel Instruments as its Distributor in Italy
8. Bausch + Lomb Signs Exclusive License Agreement with Paragon BioTeck for Phenylephrine
9. Entertainment Agency and Speaker Bureau Mark Sonder Productions Signs the Health & Wellness Shaman, Robert Cohen, PhD, LPC, DCEP for Meetings and Events Worldwide
10. Samsung Thales signs Development Agreement with Novelda
11. Eddie Leong Signs on as Advisory Board Member and Compliance Officer for Grace Century, International Research and Private Equity Consultant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... June 27, 2016  Global demand for enzymes ... through 2020 to $7.2 billion.  This market includes ... cleaning products, biofuel production, animal feed, and other ... and biocatalysts). Food and beverages will remain the ... increasing consumption of products containing enzymes in developing ...
(Date:6/27/2016)... ... June 27, 2016 , ... Newly created 4Sight ... solutions to the healthcare market. The company's primary focus is on new product ... marketing strategies that are necessary to help companies efficiently bring their products to ...
(Date:6/24/2016)... 2016 Epic Sciences unveiled a liquid ... to PARP inhibitors by targeting homologous recombination deficiency ... new test has already been incorporated into numerous ... types. Over 230 clinical trials are ... including PARP, ATM, ATR, DNA-PK and WEE-1. Drugs ...
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
Breaking Biology Technology:
(Date:6/2/2016)... LONDON , June 2, 2016 ... has awarded the 44 million US Dollar project, ... Security Embossed Vehicle Plates including Personalization, Enrolment, and IT Infrastructure ... world leader in the production and implementation of Identity Management ... in January, however Decatur was selected ...
(Date:5/20/2016)... , May 20, 2016  VoiceIt is ... partnership with VoicePass. By working together, ... experience.  Because VoiceIt and VoicePass take slightly different ... engines increases both security and usability. ... excitement about this new partnership. "This ...
(Date:4/28/2016)... and BANGALORE, India , April 28, 2016 ... a product subsidiary of Infosys (NYSE: INFY ), ... a global partnership that will provide end customers ... mobile banking and payment services.      (Logo: ... innovation area for financial services, but it also plays a ...
Breaking Biology News(10 mins):